Replies to post #121 on Sons And Daughters Of BBCMF High Technologies Comp

[mick]

Pfizer's Varenicline receives U.S. FDA priority review (PFE) 24.26 +0.26:Co announces the FDA has granted a six-month priority review for the New Drug Application for the co's smoking cessation medicine, varenicline tartrate, which the co intends to market under the brand name Champix. The FDA assigns priority review status to medicines that may provide a significant therapeutic advance over existing therapies.